U.S. Republicans wrestle with effort to gut Obamacare

Go back to U.S. Republicans wrestle with effort to gut Obamacare

CIGNA (CI) PT Raised to $164 at Oppenheimer Following 4Q Report

February 3, 2017 9:51 AM EST

Oppenheimer raised its price target on CIGNA (NYSE: CI) to $164.00 (from $158.00) while maintaining a Outperform rating following the company's 4Q report. : Following the quarter, Cigna provided conservative FY2017 EPS guidance of $9.00-9.50, but this excludes any contribution from capital deployment.

Analyst Michael Wiederhorn... More